Back
Acumen Pharmaceuticals, Inc. Stock Predictions
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
50
ABOS
Acumen Pharmaceuticals, Inc.
Last Price:
$1.99
Seasonality Move:
-34.17%
7 Day Trial
ALL ACCESS PASS
$
7
Missed $0.81? RAD Intel Now Open at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiAcumen Pharmaceuticals, Inc. Stock Forecast
-
Is Acumen Pharmaceuticals, Inc. Stock Undervalued?The current Acumen Pharmaceuticals, Inc. [ABOS] share price is $1.93. The Score for ABOS is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
ABOS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Acumen Pharmaceuticals, Inc. Stock Go Up Next Year?
Data Unavailable
Acumen Pharmaceuticals, Inc. Stock Rating
Data Unavailable
Acumen Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
acumenpharm.com
52-Week Data
52-Week High:
2.46
52-Week Low:
0.86
Prediction Charts
Market Cap:
116.9M
Price in USD:
1.93
Volume:
136.2K
Beta:
0.25
Technical Analysis
SMA50:
1.91
SMA100:
1.65
SMA200:
1.40
52-Wk Change:
-15.35%
Stock Predictions
-
Is Acumen Pharmaceuticals, Inc. stock public?Yes, Acumen Pharmaceuticals, Inc. is a publicly traded company.
-
What is the Acumen Pharmaceuticals, Inc. stock quote today?The Acumen Pharmaceuticals, Inc. stock price is 1.93 USD today.
-
How to buy Acumen Pharmaceuticals, Inc. stock online?You can buy Acumen Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-13 | 1.89 | 1.81 | 2.00 | 1.78 |
| Nov-14 | 1.76 | 1.73 | 1.80 | 1.72 |
| Nov-17 | 1.73 | 1.58 | 1.74 | 1.50 |
| Nov-18 | 1.60 | 1.66 | 1.70 | 1.56 |
| Nov-19 | 1.66 | 1.55 | 1.70 | 1.51 |
| Nov-20 | 1.58 | 1.56 | 1.72 | 1.52 |
| Nov-21 | 1.55 | 1.57 | 1.61 | 1.53 |
| Nov-24 | 1.61 | 1.70 | 1.73 | 1.61 |
| Nov-25 | 1.71 | 1.94 | 1.96 | 1.65 |
| Nov-26 | 1.94 | 1.95 | 2.03 | 1.91 |
| Nov-28 | 1.96 | 1.88 | 2.02 | 1.88 |
| Dec-1 | 1.88 | 1.90 | 1.94 | 1.84 |
| Dec-2 | 1.89 | 1.75 | 1.89 | 1.75 |
| Dec-3 | 1.76 | 1.93 | 1.94 | 1.76 |
Acumen Pharmaceuticals, Inc. Earnings
Data Unavailable
Acumen Pharmaceuticals, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.96 per share, and an increase next year of $0.55 per share.
* Acumen Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.